0.3601
12.17%
-0.0499
시장 영업 전:
.37
0.0099
+2.75%
전일 마감가:
$0.41
열려 있는:
$0.41
하루 거래량:
1.01M
Relative Volume:
1.16
시가총액:
$7.58M
수익:
$7.19M
순이익/손실:
$-50.08M
주가수익비율:
-0.00247
EPS:
-145.9978
순현금흐름:
$-48.33M
1주 성능:
-9.98%
1개월 성능:
-30.75%
6개월 성능:
-92.56%
1년 성능:
-93.09%
T 2 Biosystems Inc Stock (TTOO) Company Profile
명칭
T 2 Biosystems Inc
전화
781-457-1200
주소
101 HARTWELL AVENUE, LEXINGTON
TTOO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.3601 | 7.58M | 7.19M | -50.08M | -48.33M | -146.00 |
TMO
Thermo Fisher Scientific Inc
|
544.93 | 208.44B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
238.09 | 171.97B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
137.00 | 39.13B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
204.32 | 37.08B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
432.36 | 35.40B | 3.84B | 866.24M | 792.60M | 10.37 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-01-27 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
2020-10-08 | 개시 | BTIG Research | Buy |
2019-11-26 | 다운그레이드 | Janney | Buy → Neutral |
2019-08-01 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
2019-07-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2019-07-31 | 다운그레이드 | Janney | Buy → Neutral |
2019-05-16 | 개시 | Alliance Global Partners | Buy |
2019-03-08 | 재확인 | H.C. Wainwright | Buy |
2018-06-01 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
2018-05-30 | 재확인 | H.C. Wainwright | Buy |
2018-05-29 | 재확인 | WBB Securities | Strong Buy |
2018-03-29 | 재확인 | H.C. Wainwright | Buy |
2018-01-29 | 개시 | Goldman | Neutral |
2017-10-18 | 개시 | H.C. Wainwright | Buy |
2017-03-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2016-11-10 | 재개 | Leerink Partners | Mkt Perform |
2016-11-02 | 재확인 | Cantor Fitzgerald | Buy |
2016-07-20 | 업그레이드 | WBB Securities | Buy → Strong Buy |
2016-06-22 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
2016-04-12 | 재확인 | Canaccord Genuity | Buy |
2016-02-17 | 개시 | WBB Securities | Speculative Buy |
모두보기
T 2 Biosystems Inc 주식(TTOO)의 최신 뉴스
T2 Biosystems Reports Strong Financial Performance and Strategic Developments - Defense World
T2 Biosystems inks distribution agreement in Baltic region - LabPulse
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
T2 Biosystems Achieves Record Revenue Growth, Expands Global Reach with 27 New Instrument Contracts - StockTitan
T2 Biosystems announces board changes and incentive plan approval - Investing.com India
T2 Biosystems announces board changes and incentive plan approval By Investing.com - Investing.com South Africa
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts – T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 3 - Defense World
T2 Biosystems Enhances Governance and Leadership Stability - MSN
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - Defense World
T2 Biosystems sells four T2Dx Instruments to European distributor - MSN
T2 Biosystems expands EU presence with instrument sales By Investing.com - Investing.com Australia
Before You Invest, Make Sure You Check This T2 Biosystems Inc (NASDAQ: TTOO) Analysis - Stocks Register
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor - Nasdaq
T2 Biosystems expands EU presence with instrument sales - Investing.com
T2 Biosystems Expands European Footprint with Strategic T2Dx Instrument Sales, Breakthrough Clinical Data - StockTitan
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally - The Manila Times
T2 Biosystems' Revolutionary Sepsis Tests Hit 250K Milestone, Slash Detection Time by 77 Hours - StockTitan
T2 Biosystems extends Vizient supplier agreement By Investing.com - Investing.com Canada
T2 Biosystems extends Vizient supplier agreement - Investing.com India
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc - Marketscreener.com
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - The Manila Times
T2 Biosystems (NASDAQ:TTOO) Receives Delisting Notice from Nasdaq**Lexington, Massachusetts-based T2 Biosystems, Inc. (NASDAQ:TTOO) recently disclosed in an 8-K filing with the Securities and Exchange Commission (SEC) that it has received a notif - Defense World
T2 Biosystems stock plunges to 52-week low of $0.41 By Investing.com - Investing.com South Africa
T2 Biosystems faces Nasdaq delisting over share price - Investing.com
T2 Biosystems stock plunges to 52-week low of $0.41 - Investing.com
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens - SelectScience
T2 Biosystems to license sepsis detection tech By Investing.com - Investing.com Canada
T2 Biosystems to license sepsis detection tech - Investing.com India
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems Announces Plans to License its Proprietary - GlobeNewswire
T2 Biosystems Inc (NASDAQ: TTOO) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com Canada
T2 Biosystems stock plunges to 52-week low of $0.44 - Investing.com
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
Earnings call: T2 Biosystems reports growth and strategic partnerships By Investing.com - Investing.com UK
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
T 2 Biosystems Inc (TTOO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):